Biomarin Pharmaceutical Inc. · NASDAQ:BMRN

Capital Research Global Investors reported a 6.80% stake in Biomarin Pharmaceutical Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 13, 2025

Capital Research Global Investors reported a 6.80% stake in Biomarin Pharmaceutical Inc., 12,991,772 shares, as a passive investor on Dec 31, 2024. Filed Feb 13, 2025 (Schedule 13G/A).

Stake
6.80%
Shares
12,991,772
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
Capital Research Global Investors6.80%12,991,772

Source

View original at SEC

Related